0.18% w/v Sodium Chloride and 4.0% w/v Glucose Intravenous Infusion BP, (Viaflo Container)
*Company:
Baxter Holding B.V.Status:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company

Updated on 03 March 2025
File name
ie-spc-2023-07-g4-nacl0.18-PA2299008005-c.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 February 2025
File name
TH-30-02-191_LABEL July 2023.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 12 February 2025
File name
TH3002200_LABEL.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
- Change to date of revision
Updated on 08 April 2024
File name
ie_spc_ Sodium Chloride 0.18 & Glucose 4_PA2299-008-005_July 2023.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 August 2023
File name
NaCl 0.18 & G 4 PIL TH3002168_LABEL.pdf
Reasons for updating
- New PIL for new product
Updated on 23 January 2023
File name
ie Sodium Chloride 0.18 & Glucose 4 SPC 03.19.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 02 October 2019
File name
ie Sodium Chloride 0.18 & Glucose 4 SPC 03.19.pdf
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 September 2016
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Baxter Holding B.V.

Address:
Kobaltweg 49, 3542CE Utrecht, NetherlandsMedical Information E-mail:
medinfo_uki@baxter.comTelephone:
+44 (0)1635 206 345Medical Information Facsimile:
+44 (0)1635 206071Medical Information Direct Line:
+44 (0)1635 206345